These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2397466)

  • 1. del(3p)(p13p21) in renal cell adenoma and del(4p)(p14) in bilateral renal cell carcinoma in two unrelated patients with von Hippel-Lindau disease.
    Bergerheim US; Frisk B; Stellan B; Collins VP; Zech L
    Cancer Genet Cytogenet; 1990 Oct; 49(1):125-31. PubMed ID: 2397466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome. Region of tumor breakpoint clustering on 3p?
    Decker HJ; Neumann HP; Walter TA; Sandberg AA
    Cancer Genet Cytogenet; 1988 Jul; 33(1):59-65. PubMed ID: 3164241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease.
    King CR; Schimke RN; Arthur T; Davoren B; Collins D
    Cancer Genet Cytogenet; 1987 Aug; 27(2):345-8. PubMed ID: 3594418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome.
    Goodman MD; Goodman BK; Lubin MB; Braunstein G; Rotter JI; Schreck RR
    Cancer; 1990 Mar; 65(5):1150-4. PubMed ID: 2302664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome.
    Decker HJ; Gemmill RM; Neumann HP; Walter TA; Sandberg AA
    Cancer Genet Cytogenet; 1989 Jun; 39(2):289-93. PubMed ID: 2568884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics of renal cell carcinomas associated with von Hippel-Lindau disease.
    Kovacs G; Emanuel A; Neumann HP; Kung HF
    Genes Chromosomes Cancer; 1991 Jul; 3(4):256-62. PubMed ID: 1958591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
    Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
    Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific genetic change in tumors associated with von Hippel-Lindau disease.
    Tory K; Brauch H; Linehan M; Barba D; Oldfield E; Filling-Katz M; Seizinger B; Nakamura Y; White R; Marshall FF
    J Natl Cancer Inst; 1989 Jul; 81(14):1097-101. PubMed ID: 2738940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
    Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
    Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
    Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
    Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of renal cell carcinoma.
    Daniel LN; Linehan WM
    Semin Urol; 1989 Nov; 7(4):258-63. PubMed ID: 2575784
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishment and characterization of a renal cell carcinoma line from a patient with von Hippel-Lindau syndrome.
    Morash BA; Lee CL; Rowden G; Riddell DC; Guernsey DL
    Cancer Genet Cytogenet; 1997 Jul; 96(1):50-7. PubMed ID: 9209471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL).
    Decker HJ; Klauck SM; Lawrence JB; McNeil J; Smith D; Gemmill RM; Sandberg AA; Neumann HH; Simon B; Green J
    Cancer Genet Cytogenet; 1994 Oct; 77(1):1-13. PubMed ID: 7923076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade renal carcinoma with histologic features overlapping with renal angiomyoadenomatous tumor and featuring polysomy 7 and 17 and a mutation in the von Hippel-Lindau gene: report of a hybrid tumor and a few comments on renal angiomyoadenomatous tumor and papillary renal tumors with clear cells.
    Petersson F; Yan B; Huang J; Thamboo TP; Bing TK; Consigliere DT
    Ann Diagn Pathol; 2011 Jun; 15(3):213-6. PubMed ID: 21396864
    [No Abstract]   [Full Text] [Related]  

  • 16. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
    Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development.
    van den Berg A; Dijkhuizen T; Draaijers TG; Hulsbeek MM; Maher ER; van den Berg E; Störkel S; Buys CH
    Genes Chromosomes Cancer; 1997 Aug; 19(4):228-32. PubMed ID: 9258657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
    Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
    Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.